Australia's most trusted
source of pharma news
Sunday, 14 December 2025
Posted 29 October 2018
The only PCSK-9 inhibitor listed on the PBS will have its reimbursed use expanded from next Thursday.
Health Minister Greg Hunt has announced that Repatha, Amgen's cholesterol-lowering biological, will be available to over 6000 new patients as a result of its extension to heterozygous as well as homozygous familial hypercholesterolaemia (HoFH) from November 1.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.